Efficacy of PPV23 in Preventing Pneumococcal Pneumonia in Adults at Increased Risk--A Systematic Review and Meta-AnalysisModeling Influenza Virus Infection: A Roadmap for Influenza ResearchWhich individuals are at increased risk of pneumococcal disease and why? Impact of COPD, asthma, smoking, diabetes, and/or chronic heart disease on community-acquired pneumonia and invasive pneumococcal diseasePrevention of Community-Acquired Pneumonia with Available Pneumococcal VaccinesBurden of pneumonia and meningitis caused by Streptococcus pneumoniae in China among children under 5 years of age: a systematic literature reviewEffectiveness of pneumococcal vaccines in preventing pneumonia in adults, a systematic review and meta-analyses of observational studies.The effect of Haemophilus influenzae type b and pneumococcal conjugate vaccines on childhood pneumonia incidence, severe morbidity and mortality.Potential role for mucosally active vaccines against pneumococcal pneumoniaPneumococcal empyema and complicated pneumonias: global trends in incidence, prevalence, and serotype epidemiology.Estimating the burden of pneumococcal pneumonia among adults: a systematic review and meta-analysis of diagnostic techniquesAn evaluation of emerging vaccines for childhood pneumococcal pneumonia.Hidden epidemic of macrolide-resistant pneumococci.A systematic review of the burden of vaccine preventable pneumococcal disease in UK adults.Invasive pneumococcal disease caused by mucoid serotype 3 Streptococcus pneumoniae: a case report and literature review.Lung epithelium as a sentinel and effector system in pneumonia--molecular mechanisms of pathogen recognition and signal transductionNew vaccines for the prevention of pneumococcal infections.Comparison of dual influenza and pneumococcal polysaccharide vaccination with influenza vaccination alone for preventing pneumonia and reducing mortality among the elderly: A meta-analysisSystematic review of the effect of pneumococcal conjugate vaccine dosing schedules on prevention of pneumonia.Pneumococcal vaccination and chronic respiratory diseases.Effectiveness and practical uses of 23-valent pneumococcal polysaccharide vaccine in healthy and special populations.Multifaceted Role of Pneumolysin in the Pathogenesis of Myocardial Injury in Community-Acquired Pneumonia.Etiology and Incidence Assessment of Radiographically-confirmed Community Acquired Pneumonia (CAP)Immunogenicity of 7-Valent Pneumococcal Conjugate Vaccine in Lung Fluid of Adults With and Without HIV InfectionStudy to Identify and Characterize the Bacteria Causing Acute Otitis Media Episodes in Young Children in TaiwanSafety and Immunogenicity Study of Prophylactic Streptococcus Pneumoniae VaccineComparative Study of Ceftaroline vs. Ceftriaxone in Adults With Community-Acquired PneumoniaStudy Evaluating the Impact of a 13-valent Pneumococcal Conjugate Vaccine on Nasopharyngeal ColonizationEvaluation of Effectiveness of GSK Biologicals' Pneumococcal Conjugate Vaccine 1024850A Against Invasive DiseaseEvaluation of a Vaccine for Reducing Ear and Lung Infections in ChildrenThe Effect of Live Attenuated Inactivated Influenza Vaccine on Experimental Human Pneumococcal Carriage StudyDescription of Pneumococcal PneumoniaWhat is the Incidence of an Immune Disorder in Children With Invasive Pneumococcal Disease (IPD)?Determination of the Utility of Pfizer's Pneumococcal Urine Antigen Test in Children 5 Years of Age or Younger With Community Acquired Pneumonia in GuatemalaImpact of Prevnar 13 on Ear Infections in ChildrenImpact of GSK Biologicals' 2189242A Vaccine on Nasopharyngeal Carriage, Safety & Immunogenicity in Children & InfantsImmunological Persistence After Priming With GSK1024850A Vaccine and Safety& Immunogenicity After Booster DoseA Study to Assess the Impact of Pneumococcal Conjugate Vaccination Programme on the Carriage of PneumococciSafety and Immunogenicity of 10-valent and 13-valent Pneumococcal Conjugate Vaccines in Papua New Guinean ChildrenImmunogenicity and Safety of Two Formulations of GSK Biologicals' Pneumococcal Vaccine (2830929A and 2830930A) When Administered in Healthy InfantsPneumococcal Protein Vaccine Safety and Immunogenicity Trial
P921
Q26772119-3BA28654-0687-4D30-9D0F-1E8017D74635Q26782421-94129408-4B6D-4F72-923E-EF089D1E64D0Q26798305-0AF7C4A2-2D82-44B0-A3D6-88FFADF662D9Q28077703-5C0E45E2-226F-48F1-8011-0CBE17E7C01FQ28742681-1B7AF1E6-4452-43DE-8EAC-3F3111E3466AQ33719116-7EF35F40-8983-47FC-AE2A-5151630541B6Q33754518-7EB6F8C4-A0DE-4AF7-A506-F98BE7FFDB66Q33792681-5B7A9DBC-13A7-4422-86C8-23B555271DD1Q33947633-D90109A6-9DAE-4371-B676-E82A1515D076Q34658291-8745CE14-AE83-4F75-A442-13F51D163C77Q35595931-92F142F9-2B28-4A51-86BC-F9314754A5C0Q36009405-D0DBDEA1-913B-438A-8F8F-2A829CA5C89AQ36015061-807C3284-FF08-4639-8836-13BB3F79BF9BQ36241461-E3682A8A-4150-4A0B-AD26-31ED6E59A5E6Q36530445-98328A5B-3C75-4407-93B7-37F88BBD592FQ37091903-2EC3CB93-4DFE-4D28-9BBA-41C013C5C0FAQ37561339-821AB4FA-3F73-4CF0-8108-8CBA3D8B235CQ37621054-90BB9843-5DE0-4514-B65A-5C74ABE8BC85Q47162758-2C72CA04-E8CA-4EA5-8AA5-427A62FFD124Q48563045-D7FF75E6-1CF9-42CC-B3D0-DC71D76D0663Q53693867-C98A2A34-398F-4B11-AA74-3B8FFC7BB9A1Q61907249-163E31BE-7AC0-4C06-855E-B03E2252A9F4Q61933078-A4B748DA-36FC-40EB-9004-22414DCF2713Q61938589-145B9FA2-FE77-4127-887E-0F56883A6062Q61969674-CDEDA719-E6DF-4ABD-9DCE-CBBA7AB1AA38Q61979487-41CD8612-DE42-42AD-92E1-AECC4CA02DBDQ61979551-B5A872D7-04A6-4DE3-8108-5E4C84F62BC8Q61981413-EE63E446-6DB7-4086-BD33-233D1229CC02Q63317377-BA749E44-7D56-4D67-89AA-C3A16FF245C5Q63398675-AECC173E-50A6-4F63-B8DE-5FF014128352Q63534703-D432140A-1ED9-4BE9-8C94-F40151B341F4Q63582210-EAD66064-9839-4564-86BD-438CE5457C77Q63598415-5528FAE3-428C-4208-BF62-D63794A139E3Q63815560-30F137AD-E298-4BB3-A790-631EA6B621CDQ63817143-7E3747E1-4678-4EFD-98B6-132934B8E591Q63830525-C00F987F-DDAA-4934-8FF3-901EE4613998Q63833907-48C76915-C673-4C80-BB8C-FEC7CD096B4CQ63841499-AC7FB580-4C05-44B2-B0BF-CBD1E59853EFQ63842664-2151AAEB-AC73-4D8E-8107-F4E2E018442AQ63844982-5E3E364F-6CA2-46B0-8B72-602205D8CE40
P921
description
Krankheit
@de
human disease
@en
maladie
@fr
malattia
@it
مرض يصيب الإنسان
@ar
name
Pneumonia pneumokokus
@id
neumonía neumococal
@es
pneumococcal pneumonia
@en
pneumokokkpneumoni
@nn
pneumonie à pneumocoque
@fr
pneŭmokoka pneŭmonito
@eo
肺炎鏈球菌性肺炎
@zh
type
label
Pneumonia pneumokokus
@id
neumonía neumococal
@es
pneumococcal pneumonia
@en
pneumokokkpneumoni
@nn
pneumonie à pneumocoque
@fr
pneŭmokoka pneŭmonito
@eo
肺炎鏈球菌性肺炎
@zh
altLabel
Chest infection - pneumococcal pneumonia
@en
Lobar -pneumococcal -pneumonia
@en
Lobar pneumonia (disorder)
@en
Pneumococcal lobar pneumonia (disorder)
@en
Pneumococcal pneumonia (disorder) [Ambiguous]
@en
Pneumococcal pneumonia (disorder)
@en
Pneumococcal pneumonia [Streptococcus pneumoniae pneumonia]
@en
Streptococcus pneumonia
@en
Streptococcus pneumoniae pneumonia
@en
neumonia neumococal
@es
prefLabel
Pneumonia pneumokokus
@id
neumonía neumococal
@es
pneumococcal pneumonia
@en
pneumokokkpneumoni
@nn
pneumonie à pneumocoque
@fr
pneŭmokoka pneŭmonito
@eo
肺炎鏈球菌性肺炎
@zh
P672
P486
P6366
P1995
P2888
P31
P3827
pneumococcal-pneumonia
P486
P6366
2779892413
P672
C01.252.410.890.670.750
C01.252.620.550
C08.381.677.540.550
C08.730.610.540.550
P699
DOID:0040084
DOID:10531